September 22, 2020
“Intellia Therapeutics (NTLA)… Looking at the consensus breakdown, 3 Buys and 2 Holds have been published in the last three months. Therefore, NTLA gets a Moderate Buy consensus rating. Based on the $37.13 average price target, shares could rise 67%… Continue Reading…
September 20, 2020
“BlackRock TCP Capital (TCPC)… Overall, the analyst consensus rating here is a Moderate Buy, based on 3 Buys and 2 Holds. Shares are selling for $9.76 and the average price target matches York’s, at $11… PennyMac Mortgage (PMT)… Overall, PMT holds… Continue Reading…
September 19, 2020
“It took just 12 trading sessions for Apple to plunge more than 20% from its all-time high, shedding more than half a trillion in market capitalization. The tech giant has plunged 22.6% from its intraday record high of $137.98 from Sept. 2,… Continue Reading…
September 19, 2020
“You should trust your instincts if you’re nervous because of the wobbly action in the S&P 500 Index SPX, -1.11%, Nasdaq COMP, -1.07% and the Dow Jones Industrial Average DJIA, -0.87% since these indices got slammed in early September. Starting right about now, the stock market will see a… Continue Reading…
September 19, 2020
“Bellicum Pharmaceuticals (BLCM)… Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, BLCM gets a Moderate Buy consensus rating. Based on the $21.50 average price target, which is… Continue Reading…
September 18, 2020
“With some stocks carving out durable bottoming patterns, here are 3 Nasdaq stocks to buy: Netflix (NASDAQ:NFLX) Vertex Pharmaceuticals (NASDAQ:VRTX) First Solar (NASDAQ:FSLR) But bear in mind the Nasdaq and lopsided influencers Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT) and Amazon (NASDAQ:AMZN) still have more base building to do before a truly… Continue Reading…
September 16, 2020
“Southwest Airlines (LUV)… In line with his optimism, Shanker rates LUV an Overweight (i.e. Buy). His $54 price target implies a 33% upside for the stock in the coming year… Delta Airlines, Inc. (DAL)… Overall, the analyst consensus on Delta is a… Continue Reading…
September 16, 2020
“MediWound Ltd. (MDWD)… To this end, DeGeeter rates MDWD an Outperform along with a $7 price target. Should his thesis play out, a potential twelve-month gain of 117% could be in the cards… UroGen Pharma (URGN)… To this end, Gershell… Continue Reading…
September 15, 2020
“Venus Concept (VERO)… To this end, Thibault rates VERO a Buy along with a $7 price target. This target conveys the analyst’s confidence in VERO’s ability to climb 231% higher from current levels… Minerva Neurosciences (NERV)… What does the rest… Continue Reading…
Recent Comments